Lucas G. Hill

Lucas G. Hill, Pharm.D., FCCP serves as Adjunct Associate Professor of Pharmacy Practice at The University of Texas at Austin College of Pharmacy, maintaining a primary appointment as Associate Professor and Executive Director of the Program Evaluation and Research Unit at the University of Pittsburgh School of Pharmacy. His career bridges academic scholarship with community-engaged practice focused on substance use disorder interventions and pharmacy-based public health initiatives.

Dr. Hill earned his Pharm.D. from the University of Missouri–Kansas City School of Pharmacy and completed a combined family medicine residency and faculty development fellowship at the University of Pittsburgh Medical Center. His educational background informs his dual expertise in clinical pharmacy practice and academic leadership.

His research portfolio demonstrates sustained commitment to addressing the opioid crisis through multiple interconnected strands: improving naloxone accessibility, expanding buprenorphine dispensing in community pharmacies, developing harm reduction strategies, and implementing evidence-based educational programs. Notable projects include founding the Pharmacy Addictions Research and Medicine (PhARM) Program and directing Texas Targeted Opioid Response initiatives with over $34 million in funding.

Dr. Hill's scholarly output reveals evolving focus from foundational work on naloxone accessibility (2018-2020) toward contemporary priorities including buprenorphine access barriers, xylazine contamination challenges, and structural approaches to harm reduction. His recent publications increasingly emphasize policy implementation, interdisciplinary collaboration, and community-centered solutions.

• American College of Clinical Pharmacy Fellow (2023)
• American College of Clinical Pharmacy New Educator Award (2021)
• American Pharmacists Association Generation Rx Award of Excellence (2020)
• UT College of Pharmacy 10 Most Impactful Faculty (2022, 2018)
• American Society of Health-System Pharmacists CEO's Award for Courageous Service (2018)

As principal investigator for multiple opioid response grants totaling $38+ million from SAMHSA and other agencies, Dr. Hill has mentored numerous trainees including Claire Zagorski (WCAAR Bruce/Jones Fellowship) and Amber Tran (AMERSA Growing a Diverse Workforce Award). He serves on the Association for Multidisciplinary Education and Research in Substance Use and Addiction Board of Directors and the Journal of the American College of Clinical Pharmacy Editorial Board, while maintaining active media engagement through national interviews with CNN, NPR, and TIME.

Dr. Hill directs the Texas Opioid Training Initiative and Texas Substance Use Symposium, creating collaborative platforms for policymakers, clinicians, and community stakeholders to address substance use challenges through evidence-based approaches.